Informations générales (source: ClinicalTrials.gov)

NCT02151045 Statut inconnu
Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica - Controlled Randomized Trial With Double Blind Evaluation (EPI-AMELIE)
Interventional
  • Sciatalgie
Phase 3
University Hospital, Montpellier (Voir sur ClinicalTrials)
mars 2012
mars 2017
29 juin 2024
In discal sciatica, after failure of medical treatment, the investigators propose frequently a spinal infiltration of corticoids the most closer of disco-radicular conflict. Recently, some cases of paraplegia during lumbar foraminal infiltrations have induce a reduction of indications of this type of infiltration. An alternative would be to propose a lateral epidural infiltration on contact with conflict.The objective of this study is to compare, in 112 patients with a less than 6 months discal sciatica, the efficacy on pain of a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control versus an epidural infiltration of the same corticoid done in lateral on contact of disco radicular conflict on scan control.

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CHU Carémeau - 30000 - Nîmes - France Cécile CG GAUJOUX-VIALA, MD En recrutement Contact (sur clinicalTrials)
CHU de Montpellier - Hôpital Lapeyronie - 34295 - Montpellier - France Eric ET THOMAS, MD En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Informed consent

- Aged from 18 to 65 years

- Affiliated or benefit from an insurance regimen

- Patient with a sciatic answering to the definition

- Discal sciatica more than 15 days and less than 6 months

- Discal hernia (scan or RMI)

- Negative BHCG and normal coagulation parameters



- History of lumbar surgery

- Spinal infiltration of corticoids in 30 days before inclusion

- Iode allergy

- Anticoagulation therapy, unbalanced type 2 diabetes, instable HTA

- Motor loss < 4 (muscular testing)

- Sphincter disorder (cauda equida syndrome)